Lipella Pharmaceuticals Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Lipella Pharmaceuticals Inc. (LIPO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 9.67 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-03-31
- Lipella Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.67M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2022-12-31 | 9.67M shares 10-K · filed 2023-03-31 |